Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression (original) (raw)

• Moore, J.P., Trkola, A. & Dragic, T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551–562 (1997).
  Article CAS Google Scholar
• Berger, E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11, S316 (1997).
• Alkhatib, C. et al. CC CKR5: a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophagetropic HIV-1. Science 272, 1955–1958 (1996).
  Article CAS Google Scholar
• Deng, H. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666 (1996).
  Article CAS Google Scholar
• Dragic, T. et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature 381, 667–673 (1996).
  Article CAS Google Scholar
• Doranz, B.J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta- chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149–1158 (1996).
  Article CAS Google Scholar
• Feng, Y., Border, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872–877 (1996).
  Article CAS Google Scholar
• Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996).
  Article CAS Google Scholar
• Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–835 (1996).
  Article CAS Google Scholar
• Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).
  Article CAS Google Scholar
• Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
  Article CAS Google Scholar
• Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273, 1856–1862 (1996).
  Article CAS Google Scholar
• Moore, J.P. Coreceptors: implications for HIV pathogenesis and therapy. Science 276, 51–52 (1997).
  Article CAS Google Scholar
• Wu, L. et al. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J. Exp. Med. 185, 1681–1691 (1997).
  Article CAS Google Scholar
• Berger, E.A. et al. A new classification for HIV-1. Nature 391, 240 (1998).
  Article CAS Google Scholar
• Mummidi, S., Ahuja, S.S., McDaniel, B.L. & Ahuja, S.K., The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J. Biol. Chem. 272, 30662–30671 (1997).
  Article CAS Google Scholar
• Zimmerman, P.A. et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3, 23–36 (1997).
  Article CAS Google Scholar
• de Roda Husman, A.M. et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann. Intern. Med. 127, 882–890 (1997).
  Article CAS Google Scholar
• Michael, N.L. et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3, 338–340 (1997).
  Article CAS Google Scholar
• Meyer, L. et al. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS 11, F7378 (1997).
• Katzenstein, T.L. et al. HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16, 10–14 (1997).
  Article CAS Google Scholar
• Eugen-Olsen, J. et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS- free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 11, 305–310 (1997).
  Article CAS Google Scholar
• Morawetz, R.A. et al. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur. J. Immunol. 27, 3223–3227 (1997).
  Article CAS Google Scholar
• Huang, Y. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240–1243 (1996).
  Article CAS Google Scholar
• Garred, P. Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis? Lancet 351, 2–3 (1998).
  Article CAS Google Scholar
• Smith, M.W. et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277, 959–965 (1997).
  Article CAS Google Scholar
• Kostrikis, L.G. et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med. 4, 350–353 (1998
  Article CAS Google Scholar
• Michael, N.L. et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med. 3, 1160–1162 (1997).
  Article CAS Google Scholar
• Rizzardi, G.P. et al. CCR2 polymorphism and HIV disease. Swiss HIV Cohort. Nat Med. 4, 252–253 (1998).
  Article CAS Google Scholar
• Winkler, C. et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279, 389–393 (1998).
  Article CAS Google Scholar
• Weatherall, D., Clegg, J. & Kwiatkowski, D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res. 7, 967–973 (1997).
  Article CAS Google Scholar
• Dawson, S.J., Morris, P.J. & Latchman, D.S. A single amino acid change converts an inhibitory transcription factor into an activator.. J. Biol. Chem. 271, 11631–11633 (1996).
  Article CAS Google Scholar
• Kurumbail, R.G. et al. Structural basis for selective inhibition of cyclooxygenase–2 by anti– inflammatory agents.. Nature 384, 644–648 (1996).
  Article CAS Google Scholar
• Swofford, D.L. PAUP: Phylogenetic analysis using parsimony, Version 3.1. Computer program distributed by the Illinois Natural History Survey, Champaign, Illinois (1993).